Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MST 16

Known as: MST-16 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Anthracyclines (such as doxorubicin or daunorubicin) are among the most effective anticancer drugs, but their usefulness is… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2010
Review
2010
  • D. Lu, Ting-Ren Lu
  • Anti-cancer agents in medicinal chemistry
  • 2010
  • Corpus ID: 25242315
Bisdioxopiperazine compounds, including ICRF-154 and razoxane (ICRF-159, Raz), are anticancer agents developed in the UK… Expand
Is this relevant?
2005
2005
BackgroundAnticancer bisdioxopiperazines, including ICRF-154, razoxane (Raz, ICRF-159) and ICRF-193, are a family of anticancer… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2004
2004
SummaryWe studied bioavailability, treatment schedule dependence, and therapeutic efficacy of orally administered MST-16, a novel… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1
Is this relevant?
1999
1999
MST-16 [4,4-1,2-(ethanediyl)bis(1-isobutoxycarbonyl-oxy-methyl-2,6-pipera zinedione)], recently approved as an oral anticancer… Expand
Is this relevant?
Review
1998
Review
1998
Catalytic inhibitors of mammalian DNA topoisomerase II have been found recently in natural and synthetic compounds. These… Expand
Is this relevant?
1993
1993
Background. MST‐16, a new orally administered bis(2,6‐dioxopiperazine) analogue and an inhibitor of topoisomerase II, was given… Expand
Is this relevant?
1992
1992
Adult T cell leukemia/lymphoma (ATLL) induced by human T cell leukemia virus I is resistant to conventional therapy. Six patients… Expand
Is this relevant?
1992
1992
BACKGROUND Although razoxane (ICRF-159), a derivative of bis(2,6-dioxopiperazine), has shown significant antitumor activity in… Expand
Is this relevant?
Highly Cited
1991
Highly Cited
1991
Several recently developed derivatives of bis(2,6-dioxopiperazine) have been shown to be new antitumor agents and are currently… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?